Dissolving the Stigma around Behavioral Health: Key Takeaways | HLTH Matters GoLIVE Webinar Series

16 November 2020 Health Care Law Today Blog

A panel of health care industry leaders and subject matter experts met to discuss more accessible, convenient, and reliable patient care and the lifting of behavioral health’s stigma, hosted by HLTH on October 29, 2020 as part of the HLTH Matters GoLive Webinar Series. HLTH (pronounced “health”) is a community of leaders, innovators, and pioneers of the health industry and span across the entire health ecosystem; payers, providers, employers, investors, startups, pharma, policymakers, and the patient community to discuss the trends and strategies needed to create health’s future.

The discussion was moderated by Christopher Donovan, Partner and Co-Chair of Foley & Lardner’s Health Care Industry Team, and included panelists Sarah Ahmad (SVP of Product Innovation and Head of Magellan Health Studio at Magellan Health), Rob Marsh (SVP and COO at Kindred Behavioral Health) and Justin Hunt, MD (Medical Director and Head of Psychiatry at Ginger).

Mr. Donovan kicked off the discussion with the “three C’s” of behavioral health; 1) Cultural shift, as we’ve turned the corner from what was a stigma associated with the need for care; 2) COVID crisis and isolation have accelerated challenges and increased the need for care; and 3) Capital. There is very high interest by the investment community in this area making it an area with enormous growth.

“To demonstrate value you need to have good, reliable outcome measures.” – Dr. Justin Hunt, Medical Director and Head of Psychiatry at Ginger

Using a sports metaphor, Mr. Donovan asked the panelists where we are with behavior health and technology. Does it feel like we are in the early innings? Dr. Hunt agreed that we are still in the early innings, but sees a bright future. He believes there is “still a tremendous and widening service and delivery gap” between those seeking care and those providing care. That said, he was encouraged by the amazing amount of innovation that has resulted with the relaxing of regulatory barriers in the space. Ms. Ahmad agreed, but addressed that we are in the “first inning” in terms of sustained engagement. Mr. Marsh added his own perspective, indicating that we are in the mid-innings with regard to the understanding and acceptance of behavioral health. His view is that we are “still in the parking lot” when it comes to the collaboration and coordination among the ecosystem, and that the systems we have are disjointed.

Next, Mr. Donovan asked if there are areas of behavioral health where we can accelerate at a greater level than others are? The panelists offered a very common theme of care coordination and monitoring at both the physical well-being and behavioral level. Looking across that whole care continuum is a growth opportunity that aids transforming the experience. From the stigma perspective, offering telehealth and virtual solutions is very helpful from a privacy standpoint but technology must be secure. We must have secured platforms and be able to ensure confidentiality.

In terms of obstacles to growth, the panelists mentioned access to clinicians, redundant state-based licensing, the limitation of prescribing due to the Ryan Haight Act, and clinical severity barriers that still need to be worked through.

With many investors investing in this space, Mr. Donovan noted one concern is adequate access to clinicians. In terms of bringing clinicians into your network, Dr. Hunt offered that one thing they concentrate on at Ginger is building tools for the clinicians to make their lives easier. Mr. Marsh agreed with the access concern stating, “across the country there is a dire shortage of psychiatrists and clinicians.”

“The only way we are going to break down the stigma associated with mental health is by talking about it as often as we can and normalize the need for behavioral health. Mental health is just as important as a physical checkup.”  – Sarah Ahmad, SVP of Product Innovation and Head of Magellan Health Studio at Magellan Health

In closing the discussion, the panelists turned to the future. Down the road, when we come out of the pandemic, where will we be with behavioral health? They suggest that technology advances will continue, looking more and more at the whole person, coordinated care, and sustained engagement, as well as improved conversational AI (chatbots). In the next five years, we expect to see consolidation in the market and M&A activity, and even further out, the panelists envision that virtual reality, which allows you to face fears and anxieties in a safe, controlled environment, will be more commonplace.

You can access the full webinar by clicking here, and to learn more about the HLTH Matters GoLive Webinar Series, click here.

This blog is made available by Foley & Lardner LLP (“Foley” or “the Firm”) for informational purposes only. It is not meant to convey the Firm’s legal position on behalf of any client, nor is it intended to convey specific legal advice. Any opinions expressed in this article do not necessarily reflect the views of Foley & Lardner LLP, its partners, or its clients. Accordingly, do not act upon this information without seeking counsel from a licensed attorney. This blog is not intended to create, and receipt of it does not constitute, an attorney-client relationship. Communicating with Foley through this website by email, blog post, or otherwise, does not create an attorney-client relationship for any legal matter. Therefore, any communication or material you transmit to Foley through this blog, whether by email, blog post or any other manner, will not be treated as confidential or proprietary. The information on this blog is published “AS IS” and is not guaranteed to be complete, accurate, and or up-to-date. Foley makes no representations or warranties of any kind, express or implied, as to the operation or content of the site. Foley expressly disclaims all other guarantees, warranties, conditions and representations of any kind, either express or implied, whether arising under any statute, law, commercial use or otherwise, including implied warranties of merchantability, fitness for a particular purpose, title and non-infringement. In no event shall Foley or any of its partners, officers, employees, agents or affiliates be liable, directly or indirectly, under any theory of law (contract, tort, negligence or otherwise), to you or anyone else, for any claims, losses or damages, direct, indirect special, incidental, punitive or consequential, resulting from or occasioned by the creation, use of or reliance on this site (including information and other content) or any third party websites or the information, resources or material accessed through any such websites. In some jurisdictions, the contents of this blog may be considered Attorney Advertising. If applicable, please note that prior results do not guarantee a similar outcome. Photographs are for dramatization purposes only and may include models. Likenesses do not necessarily imply current client, partnership or employee status.

Related Services

Insights

Top Five New Telehealth Policies in Medicare 2021 in Physician Fee Schedule
02 December 2020
Health Care Law Today
IMMEX Highlights – Sub-maquila Operations
02 December 2020
Dashboard Insights
Podcast Episode 24: Steve Cade, Partner
01 December 2020
Foley Career Perspectives
European Data Protection Board Issues Recommendations for Exports of Personal Data From the European Economic Area
01 December 2020
Privacy, Cybersecurity & Technology Law Perspectives
HCCA San Francisco Regional Conference
04 December 2020
Virtual Conference
Webinar: Massachusetts Paid Family and Medical Leave 2021
02 December 2020
Webinar
CTeL Digital Health Summit 2020
01-04 December 2020
Virtual Conference
Virtual CLE Week
Every Tuesday & Thursday from December 1 - 17 2020
Webinar